Journal of Diabetes and Its Complications
Volume 20, Issue 3 , Pages 153-157 , May 2006

Glycemic control with regular versus lispro insulin sliding scales in hospitalized Type 2 diabetics

  • Abel Alfonso

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Medicine, Walter Reed Army Medical Center, Washington, DC, USA
    • Corresponding Author InformationCorresponding author. Endocrinology Service, Walter Reed Army Medical Center, Washington, DC 20307, USA. Tel.: +1 202 782 6770/6750
    • ,
  • Maureen K. Koops

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Medicine, Brooke Army Medical Center, San Antonio, TX, USA
    • ,
  • Dennis P. Mong

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Medicine, Brooke Army Medical Center, San Antonio, TX, USA
    • ,
  • Robert A. Vigersky

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Medicine, Walter Reed Army Medical Center, Washington, DC, USA

Received 11 May 2005 ,Revised 7 June 2005 ,Accepted 22 June 2005.

References 

  1. Anderson JH, Brunelle RL, Keohane P, et al. Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin dependent diabetes mellitus. Archives of Internal Medicine. 1997;157:1249–1255
  2. Anderson JH, Brunelle RL, Koivisto VA, et al. Improved mealtime treatment of diabetes mellitus using an insulin analog. Clinical Therapeutics. 1997;19(1):62–72
  3. Anderson JH, Brunelle RL, Koivisto VA, et al. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Diabetes. 1997;46:265–270
  4. Bahlinger MH, Adkins KA. Development and implementation of a standardized sliding scale insulin protocol. Journal of Clinical Outcomes Management. 2001;8:31–36
  5. Bergenstal RM, Fish LH, List S. The insulin sliding scale is not dead. Archives of Internal Medicine. 1998;158:298
  6. Bolk J, Van der Ploeg T, Cornel JH, Arnold AE, Sepers J, Umans VA. Impaired glucose metabolism predicts mortality after a myocardial infarction. International Journal of Cardiology. 2001;79:207–214
  7. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet. 2000;355:773–778
  8. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in non-diabetic and diabetic patients: A systemic overview. Stroke. 2001;32:2426–2432
  9. Cotticelli G, Bartiromo D, Ciavattone A, et al. Efficacy of insulin lispro in the control of late postprandial hypoglycemia: Comparison with regular human insulin. Minerva Medica. 2000;91(7–8):147–152
  10. DiMarchi RD, Chance RE, Long HB, Shields JE, Slieker LJ. Preparation of insulin with improved pharmacokinetics relative to human insulin through consideration of structural homology with insulin like growth factor I. Hormone Research. 1994;41(Suppl.):93–96
  11. Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. Journal of Thoracic and Cardiovascular Surgery. 2003;125:1007–1021
  12. Gallagher A, Home PD. The effect of improved post-prandial blood glucose control on post-prandial metabolism and markers of vascular risk in people with type 2 diabetes. Diabetes Research and Clinical Practice. 2005;67:196–203
  13. Garber AJ, Moghissi ES, Bransome ED, et al. American College of Endocrinology Task Force on Inpatient Diabetes and Metabolic Control: American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocrine Practice. 2004;10(1):77–82
  14. Gearhart JG, Duncan JL, Replogle WH, et al. Efficacy of sliding scale insulin therapy: A comparison with prospective regimens. Family Practice Research Journal. 1994;14(4):313–322
  15. Genuth M. The automatic (regular insulin) sliding scale, or 2,4,6,8-call H.O.. Clinical Diabetes. 1994;40–42
  16. Goldberg PA, Siegel MD, Sherwin RS, et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004;27:461–467
  17. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the U.S. in 2002. Diabetes Care. 2003;26:917–932
  18. Howey DC, Bowsher RR, Brunelle RL, Woodworth JR. [Lys(B28), Pro(B29)]-human insulin: A rapidly absorbed analog of human insulin. Diabetes. 1994;43:396–402
  19. Kiers I, Davis SM, Larkins R, et al. Stroke topography and outcome in relation to hyperglycaemia in diabetes. Journal of Neurology, Neurosurgery, and Psychiatry. 1992;55:263–270
  20. Malmberg K. Prospective randomized study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. British Medical Journal. 1997;314(7093):1512–1515
  21. Markovitz LJ, Wiechmann RJ, Harris N, et al. Description and evaluation of a glycemic management protocol for patients with diabetes undergoing heart surgery. Endocrine Practice. 2002;8(1):10–18
  22. Metchick LN, Petit WA, Inzucchi E. Inpatient management of diabetes mellitus. American Journal of Medicine. 2002;113:317–323
  23. Queale WS, Seidler AJ, Brancati FL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Archives of Internal Medicine. 1997;157(5):545–552
  24. Ross SA, Zinman B, Campos RV, Strack T. A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents. Clinical and Investigative Medicine. 2001;24(6):292–298
  25. Sawin CT. Action without benefit: The sliding scale of insulin use. Archives of Internal Medicine. 1997;157:489
  26. Trochtenberg DS. A novel insulin sliding scale. Archives of Internal Medicine. 1997;157:2524
  27. Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes. Journal of Clinical Endocrinology and Metabolism. 2002;87:978–982
  28. Van Den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. New England Journal of Medicine. 2001;345:1359–1367
  29. Velussi M. Lispro insulin treatment in comparison with regular human insulin in type 2 diabetic patients living in nursing homes. Diabetes, Nutrition & Metabolism. 2002;15(2):96–100
  30. Walts LF, Miller J, Davidson MB, Brown J. Perioperative management of diabetes mellitus. Anesthesiology. 1981;55:104–109
  31. Waybill MM, Waybill PN. Contrast media induced nephrotoxicity: Identification of patients at risk and algorithms for prevention. Journal of Vascular and Interventional Radiology. 2001;12(1):3–9

☆ Financial support statement: No author has any financial or commercial interest in any part of this study.

☆☆ Propriety statement: The views expressed in this article are those of the authors and do not reflect the official policy or position of the U.S. Army, the U.S. Department of Defense, or the U.S. Government.

PII: S1056-8727(05)00078-4

doi: 10.1016/j.jdiacomp.2005.06.009

Journal of Diabetes and Its Complications
Volume 20, Issue 3 , Pages 153-157 , May 2006

Article Tools

* Image Usage & Resolution